Metipranolol

Metipranolol
Clinical data
Trade names	Optipranolol
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a601078
ATC code	S01ED04 (WHO) C07BA68 (WHO)
Identifiers
	IUPAC name (RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate;
CAS Number	22664-55-7
PubChem (CID)	31477
IUPHAR/BPS	7239
DrugBank	DB01214
ChemSpider	29193
UNII	X39AL81KEB
KEGG	D02374
ChEMBL	CHEMBL1291
ECHA InfoCard	100.041.031
Chemical and physical data
Formula	C17H27NO4
Molar mass	309.401 g/mol
3D model (Jmol)	Interactive image
Chirality	Racemic mixture
	SMILES O=C(Oc1c(c(c(OCC(O)CNC(C)C)cc1C)C)C)C ;
	InChI InChI=1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3 ; Key:BQIPXWYNLPYNHW-UHFFFAOYSA-N ;
(verify)

Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.^[1]

References[edit]

^ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series. 4 (6): 217–223.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.